Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 1, 2009, 6:31AM ET - U.S. Markets open in 2 hours and 59 minutes. Dow Up 0.34% Nasdaq  0.00%
Orchid Cellmark Inc. (ORCH)On Nov 30: 1.53   0.00 (0.00%)  
MORE ON ORCH
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Orchid Cellmark Inc.
4390 U.S. Route One
Suite 310
Princeton, NJ 08540
United States - Map
Phone: 609-750-2200
Fax: 609-750-6405
Web Site: http://www.orchid.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Diagnostic Substances
Full Time Employees:427

BUSINESS SUMMARY 
Orchid Cellmark Inc. operates as an international provider of identity DNA testing services for the forensic, immigration, and family relationships markets. The company has laboratories in the United States and the United Kingdom; and offers its services to police forces and other government entities. It also provides non-DNA forensic laboratory services. The company’s forensic DNA testing is primarily used to confirm that a suspect committed a particular crime, to exonerate an innocent person, or to establish or maintain databases of individuals convicted of crimes; and family relationship DNA testing is used to establish whether two or more people are genetically related. Its DNA testing is used by individuals and employers in security applications to establish or store a person’s genetic profile for identification purposes in the event of an emergency or accident. The company was formerly known as Orchid Biosciences Inc. and changed its name to Orchid Cellmark Inc. in June 2005. Orchid Cellmark Inc. was founded in 1995 and is headquartered in Princeton, New Jersey.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Orchid Cellmark Inc.


    CORPORATE GOVERNANCE 
    Orchid Cellmark Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 37.4% of CGQ Universe companies and 16.4% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Thomas A. Bologna , 60
    Chief Exec. Officer, Pres
    $ 560.00K $ 0
    Mr. James F. Smith CPA, 59
    Chief Financial Officer and VP
    $ 246.00K $ 0
    Mr. William J. Thomas II, Esq, 49
    VP, Sec. and Gen. Counsel
    $ 245.00K $ 0
    Mr. Jeffrey S. Boschwitz Ph.D., 42
    VP of North America Marketing & Sales
    $ 141.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis